Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
AusPAR: Spevigo
Australian Public Assessment Report
Device/Product Name
Spevigo
Active ingredients
Spesolimab
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-01272-1-1
Submission Type
New biological entity
Decision
Approved